MMedXYNews
Ask AIHomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY News/Dermatology

Section

Dermatology

183 articles

Ask AI
All specialtiesDermatologynewsClinical UpdatesCardiologyOncology
OB/GYN & Women's Health

Oral Estrogen Therapy and Its Association with Porphyria Cutanea Tarda: Insights from a Danish Nationwide Study

A large Danish case-control study finds oral estrogen-containing therapies double the risk of incident porphyria cutanea tarda in women, highlighting the importance of administration route in risk assessment.

MedXY Editorial Team
Nov 14, 2026

Latest updates

Dermatology

Optimizing Biologic Therapy for Hidradenitis Suppurativa: Harnessing the End-of-Dose Effect to Improve Patient Outcomes

This study assesses a novel biologic optimization strategy guided by the end-of-dose effect in partial responders with hidradenitis suppurativa, revealing meaningful clinical improvements and offering a framework for personalized treatment

Nov 13, 2026
Dermatology

Long-term Safety and Sustained Control of Atopic Dermatitis in Children Treated with Ruxolitinib Cream: Insights from the Phase 3 TRuE-AD3 Trial

Ruxolitinib cream demonstrates sustained safety and effective disease control over 52 weeks in children aged 2 to 11 years with mild-to-moderate atopic dermatitis, affirming its role as a promising therapeutic option.

Nov 12, 2026
Oncology

Distinct Clinical Outcomes of Neoadjuvant PD-1 Inhibitors in Resectable Stage III Melanoma: Lymph Node Versus In-Transit Metastases

This population-based study reveals significant differences in pathological response and survival outcomes between stage III melanoma patients with lymph node metastases and those with in-transit metastases treated with neoadjuvant PD-1 inh

Nov 12, 2026
Dermatology

Low-Dose Intralesional Cemiplimab Shows Promising Efficacy in Early-Stage Cutaneous Squamous Cell Carcinoma: Insights from a Phase 1 Dose-Escalation Study

A phase 1 study demonstrates that low-dose intralesional cemiplimab is safe and achieves high complete response rates in early-stage cutaneous squamous cell carcinoma, supporting further clinical exploration.

Nov 11, 2026
Rheumatology

Targeting Nicotinamide N-Methyltransferase: A Novel Approach to Mitigate Fibroblast Activation and Skin Fibrosis in Systemic Sclerosis

This article explores the pivotal role of Nicotinamide N-methyltransferase (NNMT) in fibroblast activation and extracellular matrix deposition driving skin fibrosis in systemic sclerosis, highlighting therapeutic potential of NNMT inhibitio

Nov 10, 2026
Allergy & Immunology

Dual T Helper 17/Type 2 Immune Dysregulation in Taiwanese Psoriasis: Implications for Precision Medicine

This study reveals a distinctive dual Th17/Th2 immune endotype and pronounced IL-36 activation in Taiwanese patients with psoriasis, highlighting the need for tailored therapeutic approaches in this ethnic group.

Nov 10, 2026
Dermatology

Development and Validation of a Clinical Score for Predicting High Tuberculosis Risk in Chinese Psoriasis Patients Prior to Biologic Therapy

A multicenter Chinese study developed and externally validated the Psoriasis TB Risk Score (PTRS) to stratify psoriasis patients’ risk of high interferon-γ release assay (IGRA) responses before biologic treatment, facilitating tailore

Nov 9, 2026
Dermatology

Dupilumab Enhances Growth and Bone Health in Pediatric Severe Atopic Dermatitis: Insights from a Phase 3 Trial

Dupilumab treatment in children aged 6–11 with severe atopic dermatitis is associated with significant improvements in linear growth and bone biomarker levels over one year, suggesting benefits beyond skin clearance.

Nov 8, 2026
Dermatology

Physiological vs. Supraphysiological Platelet Concentrations in Diabetic Wound Healing: Implications from a Randomized Controlled Trial

This study demonstrates that physiological concentration platelet fibrin plasma (PFP) is noninferior to supraphysiological platelet-rich plasma (PRP) in healing neuro-ischemic diabetic foot ulcers and other diabetic wounds, offering a simpl

Nov 7, 2026
Rheumatology

Targeting IL-4 Receptor-α in Localised Scleroderma: Promising Phase 2 Evidence for Fibrosis Modulation

This phase 2 randomized trial demonstrates that IL-4-receptor-α blockade with dupilumab significantly improves clinical outcomes and reduces fibrosis-associated inflammation and gene signatures in localised scleroderma, supporting a novel t

Nov 6, 2026
Dermatology

Decoding Systemic Sclerosis: A New Vascular-Fibrotic Framework for Risk Stratification

This study introduces a novel classification framework for systemic sclerosis based on vascular and fibrotic complications, identifying a high-risk mixed endotype with distinct immunologic features and prognostic relevance, offering improve

Nov 6, 2026
Plastic Surgery

Predictors and Outcomes of Complications in Retroauricular Interpolated Flaps Following Mohs Surgery: Insights from a Large Retrospective Study

This study examines 417 retroauricular interpolated flap repairs after Mohs surgery, identifying stage-specific complication rates and risk factors such as diabetes and defect size to inform surgical risk management.

Nov 5, 2026
Dermatology

When Secondary Syphilis is Reliably Recognizable: Clinical and Histopathologic Insights into Condyloma Lata

This review synthesizes evidence on the characteristic clinical and histopathologic features of condyloma lata in secondary syphilis, emphasizing its reliable recognition to prevent misdiagnosis, especially at extragenital sites.

Nov 4, 2026Sign in to read
Dermatology

Risk Factors and Clinical Profile of Infantile Hemangioma Ulceration Post Oral Propranolol Treatment: Insights from a Large Retrospective Study

This retrospective study evaluates the incidence and risk factors for infantile hemangioma ulceration following oral propranolol therapy, highlighting subtype-related risks and anatomical protective factors to guide clinical management.

Nov 3, 2026
Plastic Surgery

Advancing Hair Loss Therapy: Sodium Citrate Enhances Comfort and Efficacy of Concentrated Growth Factor Treatment in Androgenetic Alopecia

In a randomized trial, sodium citrate as an anticoagulant in concentrated growth factor therapy for androgenetic alopecia reduced injection pain, improved hair density, and increased patient satisfaction compared with heparin sodium or no a

Nov 3, 2026
Dermatology

Safety of Biologic Therapy in Pregnancy for Psoriasis Patients: Insights from a Large Cohort Study

This large cohort study demonstrates that biologic therapy in pregnant women with psoriasis is not associated with increased adverse pregnancy outcomes and may reduce risks of spontaneous abortion and gestational diabetes.

Nov 2, 2026
Dermatology

Comparative Effectiveness and Safety of HMME-PDT Versus Pulsed Dye Laser in Treating Facial and Neck Port-Wine Stains: Insights from a Large Retrospective Study

A retrospective analysis reveals hematoporphyrin monomethyl ether-mediated photodynamic therapy (HMME-PDT) outperforms pulsed dye laser (PDL) in clearing facial and neck port-wine stains but with an increased risk of hyperpigmentation and s

Nov 1, 2026
Dermatology

Risk of Progression from Pediatric Discoid Lupus Erythematosus to Systemic Lupus Erythematosus: Insights from a Multicenter Cohort Study

This study quantifies the risk and identifies predictors for systemic lupus erythematosus development in children presenting with skin-limited discoid lupus erythematosus, highlighting the importance of early monitoring especially in patien

Oct 31, 2026
Dermatology

Cobratide Injection versus Pregabalin for Acute Herpes Zoster Neuralgia: Insights from a Multicenter Exploratory Trial

This exploratory trial compares cobratide injection and pregabalin for moderate-to-severe acute herpes zoster neuralgia, showing similar pain relief with better tolerability for cobratide and a potential reduction in postherpetic neuralgia

Oct 29, 2026
1 / 10
123…10
Next

Go deeper with MedXY AI

Explore the evidence behind the news.

Ask AI
MedXY briefing

Stay informed

Medical news and research updates, delivered to your inbox.